FBIOX Mutual Fund (Fidelity Select Biotechnology Portfolio) is managed by Fidelity Investments (US) with $7.10B in net assets. FBIOX expense ratio is 0.63%, holding 177 positions across sectors including Health Care, Unknown, Financials. Inception date: 1985-12-16.

FBIOX performance shows a YTD return of 4.65%. The 1-year return is 36.48% and the 5-year return is 5.12%. FBIOX dividend yield stands at 2.38%, paid semi-annually.

FBIOX top holdings include Abbvie Inc (16.7%), Amgen Inc. (8.2%), Gilead Sciences Inc (8.1%), Alnylam Pharmace (6.9%), Krystal Biotech Inc (6.5%). View all FBIOX holdings, sector breakdown, or dividend history.

FBIOX can be compared against other funds using the overlap calculator or side-by-side comparison tool. FBIOX alternatives are available via the screener, along with tax-loss harvesting opportunities.